ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 427

Multimedia Patient Education Tool for Patients with Rheumatoid Arthritis

Maria A. Lopez-Olivo1, Aparna Ingleshwar2, Robert Volk2, Andrea Barbo3, Maria Jibaja-Weiss4, Heather Lin5 and Maria E. Suarez-Almazor6, 1Department of General Internal Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX, 2General Internal Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX, 3Department of Biostatistics, The University of Texas, MD Anderson Cancer Center, Houston, TX, 4Office of Outreach and Health Disparities, Baylor College of Medicine, Houston, TX, 5Biostatistics, The University of Texas, MD Anderson Cancer Center, Houston, TX, 6The Department of General Internal Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: clinical trials, Education, educational innovation, patient, rheumatic education and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Title: Rheumatoid Arthritis - Clinical Aspects: Novel Biomarkers and Other Measurements of Disease Activity

Session Type: Abstract Submissions (ACR)

Background/Purpose: Effective patient education provides individuals with essential information about their disease and treatment alternatives, and aids informed decision-making. The purpose of our study was to test the efficacy of a multimedia patient education tool (MM-PtET) including storylines and testimonials for patients with rheumatoid arthritis (RA).

Methods:   Patients were recruited from 5 centers and through advertisement. Inclusion criteria were: (i) age ≥18 years (ii) diagnosis of RA by a rheumatologist (iii) disease duration ≤10 years (iii) adequate cognitive status and, (iv) ability to communicate in English or Spanish language. After completion of a baseline questionnaire, participants reviewed materials of the group to which they Patients were randomized to receive a MM-PtET or a written booklet, both with the same written information. They completed self-report questionnaires before and after viewing the assigned materials. Primary outcome measures included: a) Disease knowledge, and b) Decisional conflict. Secondary outcomes included: a) Acceptability, and b) Educational tool evaluation. We compared differences between and within groups for outcomes of interest. Linear regression was performed to assess the influence of the intervention and patient characteristics on the knowledge score. 

Results:  221 participants were randomized (111=MM-PtET, 110=written booklet). Mean age was 51±13 years, mean disease duration was 5±3 years, 85%were female 24% had inadequate health literacy levels and 41(%) were Spanish speaking. Post randomization, both, intervention and control groups, showed significantly higher knowledge scores (Intervention: 5.5±2.1 vs 7.6±1.5 and, Control: 5.5±2.1 vs 7.1±2.0; p<0.05 for both groups) and, significantly lower “Informed” and “Values clarity” scores (p<0.05 for both scales).  No statistically significant differences was observed between the two groups for knowledge improvement and decisional conflict scales (p>0.10 for both measures). The majority of the participants in both groups gave a favorable response to all evaluation questions, with no significant differences in response options observed between the two groups (p>0.05). Regarding acceptability, MM-PtET group participants were more likely to rate the presentation as “Excellent” for the following items: impact of RA, medication options, evidence about medications, benefits of medication, and self-care options (p<0.05 for all). Also, compared to the control group, more participants in the MM-PtET group found the length of the material presented as “just right” (Intervention vs Control: 92% vs 80%, p=0.03). Regression analysis indicated that, being in MM-PtET group, shorter disease duration and being Hispanic compared to White, was predictive of greater knowledge improvement (p<0.05, Adjusted R2=0.08).

Conclusion:  Viewing of the MM-PtET was as effective and more acceptable than reading written materials in RA patients. Hispanics and patients with shorter disease duration may achieve the greatest benefit from multimedia tools incorporating narratives and stories.


Disclosure:

M. A. Lopez-Olivo,
None;

A. Ingleshwar,
None;

R. Volk,
None;

A. Barbo,
None;

M. Jibaja-Weiss,
None;

H. Lin,
None;

M. E. Suarez-Almazor,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/multimedia-patient-education-tool-for-patients-with-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology